What is Directional Atherectomy?
The TurboHawk Device is a catheter-based device that includes a directional cutter that can be positioned to address the area of greatest plaque burden within a vessel and maximize luminal gain for better results.1 The High Efficiency Cutter in the device can now treat all plaque morphologies — above and below the knee.2
How Prevalent is PAD?
Despite its pathophysiology, PAD is still largely undiagnosed. Of the estimated 8 to 12 million Americans that suffer from the disease, only about 25% are treated.3
Covidien makes it easy for clinicians to get started and offer this technology to patients. Talk with your local sales representative about our PACE program-sponsored educational opportunities that include didactic learning, small group discussions, hands-on training, case observations, and dinner programs where you can learn more about the clinical evidence that supports the therapy.
If you are a healthcare professional interested in more information, please contact us.
- Aboufakher R, Torey J, Szpunar S, et al. Peripheral Plaque Volume Changes Pre- and Post-rotational Atherectomy followed by Directional Plaque Excision: Assessment by Intravascular Ultrasound and Virtual Histology. J Invasive Cardiol. 2009;21:501-505.
- Large vessel catheters: When used in hard, complex calcified lesions the TurboHawk catheter should be paired with SpiderFX™ Embolic Protection Device to mitigate the risk of distal embolization. Small vessel catheters: Do not use in hard, complex calcified lesions due to the risk of distal embolization that may result from excising this type of lesion.